Skip to main content
Top
Published in: Reactions Weekly 1/2022

01-06-2022 | Bisoprolol | Case report

Ivabradine

Congenital disorders following in utero exposure: 2 case reports

Published in: Reactions Weekly | Issue 1/2022

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Hoeltzenbein M, et al. Ivabradine use in pregnant women-treatment indications and pregnancy outcome: an evaluation of the German Embryotox database. European Journal of Clinical Pharmacology 77: 1029-1037, No. 7, Jul 2021. Available from: URL: http://doi.org/10.1007/s00228-020-03066-w Hoeltzenbein M, et al. Ivabradine use in pregnant women-treatment indications and pregnancy outcome: an evaluation of the German Embryotox database. European Journal of Clinical Pharmacology 77: 1029-1037, No. 7, Jul 2021. Available from: URL: http://​doi.​org/​10.​1007/​s00228-020-03066-w
Metadata
Title
Ivabradine
Congenital disorders following in utero exposure: 2 case reports
Publication date
01-06-2022
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-17959-8

Other articles of this Issue 1/2022

Reactions Weekly 1/2022 Go to the issue

Case report

Deferoxamine

Case report

Dexamethasone

Case report

Cisplatin

Case report

Multiple drugs